Current Opinion in Organ Transplantation

Papers
(The TQCC of Current Opinion in Organ Transplantation is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?54
Delayed graft function: current status and future directions27
Editorial: Organ Preservation Revolution: the future is revisiting the past through a different lens26
HLA-DQ antibodies in alloimmunity, what makes them different?25
Urine CXCL10 as a biomarker in kidney transplantation24
Editorial introductions21
Overview of pregnancy in solid-organ transplantation21
Deceased donors with multidrug-resistant organisms: implications and future directions19
Using organ perfusion to optimize donor livers19
Update on surgical management of enteroatmospheric fistulae in intestinal failure patients18
The perspective for next-generation lung replacement therapies: functional whole lung generation by blastocyst complementation18
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation17
Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients16
Obesity and kidney transplantation16
Equity in liver transplantation: are we any closer?15
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?14
Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions14
The ethics of donation after circulatory death organ recovery: an overview of new considerations arising from procurement practice and policy changes13
Modifying organs with gene therapy and gene modulation in the age of machine perfusion12
What is needed to ensure long-term sustainability for the field of vascularized composite allotransplantation?12
Respiratory viral infections including COVID-19 in solid organ transplantation11
Establishing an upper extremity transplantation program: lessons learnt over 12 years11
Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease11
Language and cultural concordance to promote equity in organ transplantation for Hispanics with limited English proficiency11
The sex disparity in liver transplantation10
Regulatory dendritic cell therapy in organ transplantation10
Cardiac evaluation of the liver transplant candidate9
A review of transplant infectious diseases and pediatric transplant infectious diseases curriculum9
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients9
Noninvasive methods to reduce cardiac complications postheart transplant9
Novel agents in the treatment of invasive fungal infections in solid organ transplant recipients9
Machine perfusion in liver transplantation: recent advances and coming challenges9
Beyond donation to organ utilization in the UK9
Management of the sensitized heart transplant candidate9
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation9
A cystic fibrosis patient9
Social support and transplantation8
Ethical issues in organ procurement: donation after normothermic regional perfusion in liver transplantation8
Defining chronic rejection in vascularized composite allografts – do we have reliable surrogates to look for?8
Donor-derived infections in solid organ transplant recipients8
Living liver donor pain management8
Future directions for xenotransplantation in lungs8
Nontransplant options for portomesenteric thrombosis7
The road to xenotransplantation7
Management of long-term cardiovascular risk factors post organ transplant: Erratum7
Editorial introductions7
Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation7
Lung preservation: from perfusion to temperature7
Grasping time – longevity of vascularized composite allografts7
Adherence in transplantation6
Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how6
Editorial introductions6
Pediatric intestinal rehabilitation6
The role of living donor liver transplantation in colorectal cancer liver metastases6
Social and biologic determinants in lung transplant allocation6
Editorial introductions6
Potential options to expand the intestinal donor pool: a comprehensive review6
Unraveling the spectrum of airway complications following lung transplantation: a comprehensive overview6
Ethical considerations in lung re-transplantation6
Kidney organ allocation: reducing discards6
Optimizing cardiac status in the preliver transplant candidate6
Advances in desensitization for human leukocyte antigen incompatible kidney transplantation6
DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics?6
Thoraco-abdominal normothermic regional perfusion for thoracic transplantation in the United States: current state and future directions6
Normothermic regional perfusion for donation after circulatory death donors6
Cell-free DNA in lung transplantation: research tool or clinical workhorse?6
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics6
0.13438987731934